Tomocube Inc
475960
Company Profile
Business description
Tomocube Inc is a technology-based company that provides solutions in life science research and diagnosis. The group's Core technology, holotomography, is a non-invasive imaging technique that uses light diffraction to acquire three-dimensional images of cells and tissues without dyeing or labeling. Its products and applications are Holotomography includes HT-X1, HT-X1, and HT-2H, TomoAnalysis, Accessories Cell biology, Regenerative medicine, 3D biology, Immunology, and LLPS.
Contact
155 Shinsung-ro
4th floor
Yuseong-gu
Daejeon34109
KORT: +82 428631100
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
76
Stocks News & Analysis
stocks
We remove our Moat Rating from ASX listed share
Despite a surging share price a weakening competitive position causes a reassessment of our view.
stocks
Best sustainable companies to own in 2026
We believe these companies’ strong ESG management practices give them a long-term advantage.
stocks
New data centre deal for ASX listed REIT
New parternship adds to a growing data centre pipeline in fiscal 2026.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,034.70 | 2.20 | -0.02% |
| CAC 40 | 8,195.21 | 45.71 | 0.56% |
| DAX 40 | 24,539.34 | 48.93 | 0.20% |
| Dow JONES (US) | 48,382.39 | 319.10 | 0.66% |
| FTSE 100 | 9,951.14 | 19.76 | 0.20% |
| HKSE | 26,361.56 | 23.09 | 0.09% |
| NASDAQ | 23,235.63 | 6.36 | -0.03% |
| Nikkei 225 | 51,832.80 | 1,493.32 | 2.97% |
| NZX 50 Index | 13,587.23 | 38.81 | 0.29% |
| S&P 500 | 6,858.47 | 12.97 | 0.19% |
| S&P/ASX 200 | 8,728.60 | 2.60 | 0.03% |
| SSE Composite Index | 4,022.60 | 53.76 | 1.35% |